ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,132.67
1.35%
Dow Jones
38,709.88
1.27%
US Dollar vs MXN
16.9773
0.03%
Brent Oil
83.075
-0.66%
Bitcoin
61,912.96
4.72%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) Noticias

MRSN Mersana Therapeutics Inc

3.445
0.085 (2.53%)
Última actualización: 12:49:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mersana Therapeutics Inc MRSN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.085 2.53% 3.445 12:49:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.52 3.44 3.63 3.36
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:00GLOBEMersana Therapeutics to Host First Quarter 2024 Conference..
04/4/202415:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
28/2/202415:08EDGAR2Form 8-K - Current report
28/2/202415:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202415:05EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202407:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202407:43EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
28/2/202406:07EDGAR2Form 8-K - Current report
28/2/202406:00GLOBEMersana Therapeutics Provides Business Update and..
27/2/202407:01GLOBEMersana Therapeutics to Present at Upcoming Investor..
21/2/202407:00GLOBEMersana Therapeutics to Host Fourth Quarter and Year End..
16/2/202415:30EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/2/202419:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:43EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202408:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202407:00GLOBEMersana Therapeutics to Participate in Guggenheim’s 6th..
17/1/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202420:14EDGAR2Form 144 - Report of proposed sale of securities
16/1/202420:13EDGAR2Form 144 - Report of proposed sale of securities
16/1/202420:13EDGAR2Form 144 - Report of proposed sale of securities
12/1/202415:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/1/202407:06EDGAR2Form 8-K - Current report
05/1/202407:01GLOBEMersana Therapeutics Announces Business Updates, Expected..
04/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:11EDGAR2Form 8-K - Current report
01/12/202315:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
07/11/202307:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:18EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEMersana Therapeutics Provides Business Update and Announces..
31/10/202315:30GLOBEMersana Therapeutics to Host Third Quarter 2023 Conference..
31/10/202311:59DJNMersana Therapeutics Shares Rise 8% After FDA Lifts Clinical..
31/10/202308:07DJNMersana Says FDA Lifts Clinical Hold on Gastric-Cancer..
31/10/202307:12EDGAR2Form 8-K - Current report
31/10/202307:00GLOBEMersana Therapeutics Announces FDA has Lifted Clinical Hold..
27/10/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202307:27EDGAR2Form 8-K - Current report
07/9/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202316:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
MRSN
Mersana Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados